BIERCHAMPS PHARMA
0831.803.308 · rovalta.com · 24/09/2026
NORMAL SITUATION
BIERCHAMPS PHARMA
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result41,4 k €-10,6 %over 1 year
Equity221 k €+23,1 %over 1 year
Overview
Identity
Source · BCE/KBOBIERCHAMPS PHARMA is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0831.803.308
- Legal form
- Private company with limited liability
- Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2022
Joint committees (1)
- 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | – | – | 286,2 k € | +2.5% | 279,2 k € | +6.5% | 262,2 k € | ||
| EBITDA | 58,7 k € | -23.7% | 77 k € | -26.1% | 104,2 k € | -26.9% | 142,6 k € | +6.9% | 133,4 k € |
| Operating result | 53,2 k € | -17.3% | 64,3 k € | +42.0% | 45,3 k € | -34.8% | 69,5 k € | +8.8% | 63,9 k € |
| Net result | 41,4 k € | -10.6% | 46,3 k € | +67.6% | 27,6 k € | -30.4% | 39,7 k € | +24.9% | 31,8 k € |
| Balance sheet | |||||||||
| Equity | 221 k € | +23.1% | 179,6 k € | +34.8% | 133,3 k € | +26.2% | 105,6 k € | +60.3% | 65,9 k € |
| Total assets | 228,4 k € | +19.1% | 191,7 k € | -53.7% | 413,6 k € | -10.1% | 460,3 k € | -4.6% | 482,7 k € |
| Cash | 14,3 k € | -20.3% | 17,9 k € | -84.1% | 112,7 k € | -6.6% | 120,6 k € | +42.8% | 84,5 k € |
| Debts | 7,3 k € | -39.3% | 12,1 k € | -95.7% | 280,3 k € | -21.0% | 354,7 k € | -14.9% | 416,8 k € |
| Other | |||||||||
| Workforce | – | 2,6 ETP | -25.7% | 3,5 ETP | 0.0% | 3,5 ETP | +2.9% | 3,4 ETP | |
Board of directors
Source · NBB, accounts to 31/12/20224 active · 3 ended
Active mandates
Jean-Paul KNAEPEN
ActiveMichaël MYNSBERGHE
ActivePascal PEETERS
ActiveThomas CALANDE
ActiveEnded mandates
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/06/2023 | 03/08/2022 | 28/05/2021 | 24/10/2020 | 04/09/2019 | 13/07/2018 |
| General meeting | 13/06/2023 | 14/06/2022 | 22/04/2021 | 01/09/2020 | 03/09/2019 | 12/07/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2022 | 13/06/2023 | 13/06/2023 | French | |
| Full model | 31/12/2021 | 14/06/2022 | 03/08/2022 | French | |
| Abridged model | 31/12/2020 | 22/04/2021 | 28/05/2021 | French | |
| Abridged model | 31/12/2019 | 01/09/2020 | 24/10/2020 | French | |
| Abridged model | 31/12/2018 | 03/09/2019 | 04/09/2019 | French | |
| Abridged model | 31/12/2017 | 12/07/2018 | 13/07/2018 | French | |
| Abridged model | 31/12/2016 | 20/06/2017 | 22/08/2017 | French | |
| Abridged model | 31/12/2015 | 13/09/2016 | 26/09/2016 | French | |
| Abridged model | 31/12/2014 | 16/06/2015 | 24/08/2015 | French | |
| Abridged model | 31/12/2013 | 23/09/2014 | 24/09/2014 | French | |
| Abridged model | 31/12/2012 | 28/03/2013 | 10/04/2013 | French | |
| Abridged model | 31/12/2011 | 12/06/2012 | 13/06/2012 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20224 active · 3 ended
Active mandates
Jean-Paul KNAEPEN
ActiveMichaël MYNSBERGHE
ActivePascal PEETERS
ActiveThomas CALANDE
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution06/06/2023RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Restructuring28/02/2023RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates12/12/2022DEMISSIONS, NOMINATIONS
- Mandates06/12/2021DEMISSIONS, NOMINATIONS
- Mandates03/06/2021SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates29/10/2014DEMISSIONS, NOMINATIONS
- Registered office06/05/2014SIEGE SOCIAL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 202241,4 k €↓
- 2021Annual accounts 202146,3 k €↑
- 2020Annual accounts 202027,6 k €↓
- 2019Annual accounts 201939,7 k €↑
- 2018Annual accounts 201831,8 k €↑
- 2017Annual accounts 20177,1 k €↓
- 2016Annual accounts 20169 k €↓
- 2015Annual accounts 20159 k €↑
- 2014Annual accounts 20145,7 k €↑
- 2013Annual accounts 2013-1,9 k €↓
- 2012Annual accounts 20123,4 k €↑
- 2011Annual accounts 2011-10,4 k €